• Heart Failure clinical trials from ESC Congress 2024

  • Sep 16 2024
  • Length: 24 mins
  • Podcast

Heart Failure clinical trials from ESC Congress 2024

  • Summary

  • With Jozine ter Maaten, University Medical Center Groningen - The Netherlands, Antonio Cannata, King's College London - UK, Mateusz Sokolski, Wroclaw Medical University - Poland, Henrike Arfsten, Medical University of Vienna - Austria, Stefan Anker, Charité University Hospital Berlin - Germany, Muthiuh Vaduganathan, Brigham and Women's hospital, Harvard Medical School Boston - USA, Cornelia Margineanu, Bucharest – Romania and Kengo Kusano, National Cerebral and Cardiovascular Center Hospital, Osaka - Japan.

    In this multivoice podcast from the ESC Congress 2024, the main results of three randomized controlled clinical trials (FINEARTS-HF, RESHAPE-HF2, and CRABL-HF) are discussed.

    Links to the papers:

    FINEARTS-HF

    RESHAPE-HF2

    This 2024 HFA CardioTalk podcast serie is supported by Novartis in the form of an educational grant. The discussion has not been influenced in any way by its sponsor.

    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Heart Failure clinical trials from ESC Congress 2024

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.